Melanoma Center - Membership

Gavin P. Robertson, Ph.D., Director

Professor of Pharmacology, Pathology, Dermatology, and Surgery, Director, Melanoma Therapeutics Program, Director, Foreman Foundation Melanoma Research Laboratory

Area(s) of interest:  Experimental Therapeutics Agent development for treatment of Melanoma, Apoptosis, Metastasis, Nanotechnologies, Liposomes, and RNAI

Rogerio I. Neves, M.D., Ph.D., Deputy Director

Professor of Surgery, Dermatology, Pharmacology and Medicine Director, Cutaneous Oncology Program, Clinical Science Leader, Melanoma Therapeutics Program

Area(s) of interest: Cutaneous oncology, including prevention, diagnosis, treatment and research of melanoma, cutaneous sarcomas and other skin cancers. 

Colette Pameijer, M.D., FACS Associate Director for Translational Research

Associate Professor of Surgery

Area(s) of interest: Melanoma, miRNA profiling, Sentinel node imaging and Regional therapy for advanced malignancies.

Bryan Anderson, M.D.,  Associate Director for Oncologic Dermatology

Professor of Dermatology

Area(s) of interest: Contact Dermatitis, Psoriasis, Cutaneous T-Cell Lymphoma, and Melanoma

Genevieve Ann (Ambrose) Andrews, M.D.,  Associate Director for Surgical Oncology

Assistant Professor of Surgery

Areas of interest: Otolaryngology - Head and Neck Oncology Surgery and Cutaneous Malignancies of the Head and Neck

Joseph Drabick, M.D., Associate Director for Translational Oncology

Professor of Medicine

Area(s) of interest:  Melanoma and Clinical trials

Edward Fox, M.D., Associate Director for Bone and Soft Tissue Sarcomas


Area(s) of interest: Orthopaedic Musculoskeletal Oncology Surgery, Sarcomas, and Metabolic Bone Diseases including Osteoporosis.

Klaus Helm, M.D., Associate Director for Dermatopathology

Professor of Dermatology

Area(s) of interest: Dermatopathology

Heath Mackley, M.D., Associate Director for Radiation Oncology

Associate  Professor of Radiology, Medicine, and Pediatrics

Area(s) of interest: Head and Neck malignancies, Gastrointestinal malignancies, Gynecologic malignancies, Cutaneous malignancies, Sarcomas, Population research, Advanced Radiation Technologies, Radio-surgery.

Douglas Stairs, Ph.D, Associate Director, Non-melanoma Basic Research

Assistant Professor of Pathology; Director, Molecular and Histopathology Core Penn State College of Medicine

Area(s) of interest:  genetic modeling in tissue culture and mouse model systems combined with biochemical, pharmacologic and cell & molecular biology techniques

A B  Madhankumar, Ph.D.

Assistant Professor of Neurosurgery

Area(s) of interest: Nanotechnology and Neuroscience, Exosomes and microvesicles

Adam Glick, Ph.D.

Associate Professor, Department of Veterinary and Biomedical Sciences

Area(s) of interest: Molecular mechanisms and signaling pathways that regulate progression of squamous tumors from a benign to malignant phenotype. He also works on analysis of the tumor suppressor and oncogenic roles of Transforming Growth Factor Beta in multistage skin carcinogenesis using novel transgenic and knockout mouse models.

Amanda Cooper, M.D.

Assistant Professor of surgery, Division of General Surgery Specialties and Surgical Oncology, The Program for Liver, Pancreas, Foregut Tumors

Area(s) of interest:  Surgical Oncology, gastroenterology (GI) tract, abdominal, and retroperitoneal malignancies.

Andrea L. Zaenglein M.D.

Professor of Dermatology and Pediatric Dermatology

Area(s) of Interest:  Pediatric Dermatology, Acne Vulgaris, Genetic Skin Disorders

Anna Leung, M.D.

Assistant Professor of Surgery, Department of Surgery

Area(s) of Interest: Melanoma immunotherapeutics, Cytoreductive surgery,Management of advanced malignancies, Clinical trial design

Arthur Berg, Ph.D.

Associate Professor of Public Health Sciences and Statistics; Lead Statistician, Melanoma and Skin Cancer Center

Area(s) of Interest:  Statistical Genetics, Time Series Analysis, Survival Analysis, Functional Smoothing, Bootstrap, Subsampling, Nonparametric Statistics, Density Estimation, Simulation, Bayesian Statistics, and Longitudinal Data Analysis

Arun Sharma, Ph.D.

Associate Professor of Pharmacology

Area(s) of interest:  Organic Synthesis Core, development of novel molecules for cancer therapy and prevention, testing in in vitro and in vivo cancer models, optimization of naturally occurring agents, existing drugs, and efficacy

Catherine G. Chung, M.D.

Assistant Professor of Dermatology and Pathology

Areas of interest: Cutaneous lymphoma, granulomatous and histiocytic disorders

Cheng Dong, Ph.D.

Professor of Bioengineering

Area(s) of interest:  Tumor Micro-environment leukocytes and endothelial immune functions which effect Cancer Metastasis. Micro-hemodynamics, cell adhesion and signaling

Cindy Naret, B.A.

Director, Clinical Trial Office, Penn State Cancer Institute


Area(s) of interest: Clinical Trials.


Craig Meyers, Ph.D

Distinguished Professor of Microbiology and Immunology 

Area(s) of interest:  Immunology and microbiology

David Goldenberg MD, FACS

Chief, Division of Otolaryngology- Head and Neck Surgery, Professor of Surgery and Oncology, Director of Head and Neck Surgery, Associate Director of Surgical Services- Penn State Cancer Institute

Area(s) of interest: head and neck cancer, thyroid cancer as well as parathyroid disease, Da Vinci TransOral Robotic Surgery (TORS) and Minimally invasive radioguided parathyroidectomy (MIRP).

David L. Shupp, MD

Assistance Professor of Dermatology

Area(s) of Interest:  Dermatology, Dermatologic Surgery

Dhimant Desai, Ph.D.

Associate Professor of Pharmacology

Areas(s) of interest:  Structural activity relationship of organic chemopreventive and chemotherapeutic agents against cancers of colon, lung, melanoma, and leukemia

Elizabeth Magill Billingsley, MD,

Professor of Dermatology, Director of Mohs Micrographic Surgery

Area(s) of interest:  Mohs micrographic surgery, non-melanoma skin cancer resection and reconstruction, skin cancer prevention, and basal cell nevus syndrome

Elizabeth V. Seiverling, M.D.

Assistant Professor, Department of Dermatology

Area(s) of interest:  Early detection of  skin cancer (melanoma, basal cell, and squamous cell) using dermoscopy.  Skin rashes due to chemotherapy

Eugene Lengerich, VMD MS

Professor of Public Health Sciences; Interim Associate Director, Population Science, Penn State Cancer Institute; Director, Public Health Preparedness, Intercollege Masters of Professional Studies in Homeland Security

Area(s) of interest:  participatory, data-based approaches to develop, test, and disseminate evidence-based strategies for the clinic and public health; investigation of diseases that affect both human and animal populations, leading to a collaborative, one-health, approach to disease prevention and public health preparedness

Gary Clawson, M.D., Ph.D.

Professor of Pathology

Area(s) of interest:  Early changes in Carcinogenesis.

George-Lucian Moldovan, PhD

Assistant Professor of Biochemistry and Molecular Biology

Area(s) of interest: DNA damage response, UV-induced mutagenesis, Genomic instability

Harold A. Harvey, MD

Professor of Medicine; Director, Hematology/Oncology Fellowship Program

 Area(s) of interest:  Medical Oncology, Hormonal Therapy of Breast Cancer, medical education, minority issues

Hong-Gang Wang, Ph.D

Lois High Berstler Professor of Pharmacology

Area(s) of interest: Understanding the fundamental mechanisms that control apoptosis and autophagy in the context of oncogenesis

James Adair, Ph.D

Professor of Material Sciences

Area(s) of interest:  Material Sciences

James Connor, Ph.D

Professor of Neurosurgery

Area(s) of interest: Regulation of Expression of Iron Binding Proteins in the Nervous system

Jeffrey M. Peters, Ph.D., A.T.S.

Distinguished Professor, Center for Molecular Toxicology and Carcinogenesis, Department of Veterinary and Biomedical Sciences

Area(s) of interest: Non-melanoma skin cancer, chemoprevention, nuclear receptors, peroxisome proliferator-activated receptors

Jianxun Song, Ph.D

Assistant Professor, Microbiology and Immunology


Area(s) of interest: Co-stimulation in T lymphocyte memory and Immune cell differentiation from induced pluripotent stem cells


Jin-Ming Yang, M.D., Ph.D.

Professor of Pharmacology


Area(s) of interest: The molecular determinants of sensitivity/resistance to anticancer treatments and the signal transduction alteration in malignant cells during cancer progression


Joyce Wong, MD


Area(s) of interest: Liver, Pancreas, and Foregut Program; General Surgery, Surgical Oncology

Keith Cheng,M.D., Ph.D.

Professor of Pathology, Biochemistry and Molecular Biology, and Pharmacology

Area(s) of interest: Fundamental genetic and molecular mechanisms that cause cancer, basic mechanisms underlying the relationship between human skin pigmentation and cancer.

Kimberly Mallett, Ph.D.

Clinical Director: Bio-behavioral Health

Area(s) of interest: Targeted therapies for brain tumors and other neuro-degenerative diseases

Krishne Gowda, PhD

Assistant Professor of Pharmacology

Area(s) of interest: organic chemistry, biochemical, and molecular biological tools in an interdisciplinary approach to designing drugs that specifically target diseased cells or infectious agents.

Lisa Shantz Ph.D

Associate Professor, Cellular and Molecular Physiology and the Penn State Cancer Institute; Project Manager for the Woodward Endowment for Medical Science Education

Area(s) of interest:  Signal transduction pathways in non-melanoma skin carcinogenesis

Mike Ioffreda, MD

Professor of Dermatology and Pathology       

Area(s) of interest:  dermatopathology of melanoma and non-melanoma skin cancers

Niraj J. Gusani, MD, MS, FACS

Associate Professor of Surgery, Medicine, & Public Health Sciences Section of Surgical Oncology Penn State College of Medicine; Director, Program for Liver, Pancreas, & Foregut Tumors Penn State Cancer Institute

Area(s) of interest:  Clinical outcomes in Gastrointestinal Oncology,  Clinical outcomes in Hepato-pancreato-biliary Oncology,  Clinical outcomes in Melanoma and Sarcoma, Clinical outcomes in Endocrine Malignancies,  Survivorship and Quality of Life in Gastrointestinal, Hepatobiliary, and Surgical Oncology Patients,  Epidemiology and Population-based Outcomes in Surgical Oncology,  Racial and Socioeconomic Disparities in Cancer Care,  Role of Physical Activity and Prehabilitation in the Outcomes of Patients Undergoing Gastrointestinal Cancer Surgery

Raghavendra Gowda, Ph.D.

Research Associate

Area(s) of interest: Melanoma Targets, Drugs and Delivery System

Rob Turrisi, Ph.D.

Director: Bio-behavioral Health

Area(s) of interest: His research focus is in the application of psychological theories of behavioral decision-making and multivariate statistical modeling to adolescent health issues and family relationships. Dr. Turrisi also has an interest in brief interventions to prevent substance abuse and cancer.

Sara B. Ferguson, M.D.

Assistant Professor of Dermatology

Area(s) of interest: Dermatology, weet syndrome, rare diseases, Crohn's

Shantu Amin, PH.D

Professor of Pharmacology; Director of Organic Core Synthesis

Area(s) of interest:  Developing syntheses and providing cancer related chemical carcinogens and chemopreventive agents

Siyang Zheng, Ph.D

Dorothy Quiggle Assistant Professor of Bioengineering


Area(s) of interest:  BioMEMS and Nanotechnology


Todd V. Cartee, M.D.

Assistant Professor of Dermatology

Area(s) of interest:Cutaneous oncology, including early detection, management, and surveillance of melanoma and Mohs micrographic surgery for non-melanoma skin cancer

Todd Schell, Ph. D.

Associate Professor Microbiology and Immunology; Faculty Director, Flow Cytometry Core Facility

Area(s) of interest: T lymphocyte response to cancer, Immunotherapy for cancer

Thomas A. Davidowski, M.D.

Assistant Professor of Dermatology

Area(s) of interest:  Dermatology

Yanming Wang, Ph.D.

Assistant Professor of Biochemistry and Molecular Biology 

Area(s) of interest:  Epigenetic histone modifications in cell differentiation and cancer.

Qing Yang, Ph.D.

Associate Professor of Radiology

Area(s):  Brain mapping with functional MRI, In vivo pathological evaluation of Alzheimer's disease with quantitative MRI.